title: [Postoperative features in lung cancer patients receiving intraoperative radiotherapy and radiosensitization].
abstract: Research Institute of Oncology, Research Center, Russian Academy of Medical Sciences, Siberian Branch, Tomsk. Postoperative course was studied of stage III non-small cell lung cancer (35) treated radically using intraoperative radiotherapy (15Gy) and cisplatin radiosensitization. Postoperative complications were reported in 11.4 +/- 5.4%. Reduction in complication rates was due to the use of a combined treatment complex. There were no postoperative lethalities.
authors.forename: A Iu
authors.initials: AIu
authors.lastname: Dobrodeev
authors.forename: A A
authors.initials: AA
authors.lastname: Zav'ialov
authors.forename: S A
authors.initials: SA
authors.lastname: Tuzikov
authors.forename: S V
authors.initials: SV
authors.lastname: Miller
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Rudyk
mesh_terms: D000328:Adult; D000368:Aged; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007430:Intraoperative Care; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000009:adverse effects; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome
chemical_list: D011838:Radiation-Sensitizing Agents; D002945:Cisplatin